Reasons for cannabis use: patients with schizophrenia versus matched healthy controls

References

• Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990; 16: 31–56
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511–2518
   PubMed Web of Science ®Google Scholar
• Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1991; 148: 224–230
   PubMed Web of Science ®Google Scholar
• Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005; 19: 187–194
   PubMed Web of Science ®Google Scholar
• Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273–279
   PubMed Web of Science ®Google Scholar
• Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR. Cannabis consumption as a prognostic factor in schizophrenia. Br J Psychiatry 1995; 164: 679–681
   Web of Science ®Google Scholar
• Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med 1992; 20(Suppl)1–97
   Google Scholar
• Degenhardt L, Tennant C, Gilmour S, et al. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med 2007; 37: 927–934
   PubMed Web of Science ®Google Scholar
• Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142: 1259–1264
   PubMed Web of Science ®Google Scholar
• Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997; 4: 231–244
   PubMed Web of Science ®Google Scholar
• Schneier FR, Siris SG. A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. J Nerv Ment Dis 1987; 175: 641–652
   PubMed Web of Science ®Google Scholar
• Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370(9584)319–328
   PubMed Web of Science ®Google Scholar
• Ferdinand RF, van der Ende J, Bongers I, Selten JP, Huizink A, Verhulst FC. Cannabis: psychosis pathway independent of other types of psychopathology. Schizophr Res 2005; 79: 289–295
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33: 15–21
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330(7481)11
   PubMed Web of Science ®Google Scholar
• Noordsy DL, Drake RE, Teague GB, et al. Subjective experiences related to alcohol use among schizophrenics. J Nerv Ment Dis 1991; 179: 410–414
   PubMed Web of Science ®Google Scholar
• Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997; 96: 329–333
   PubMed Web of Science ®Google Scholar
• Test MA, Yallisch LS, Allness DJ, Ripp K. Substance use in young adults with schizophrenics disorders. Schizophr Bull 1989; 15: 465–476
   PubMed Web of Science ®Google Scholar
• Hamera E, Schneider JK, Deviney S. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis 1995; 183: 559–565
   PubMed Web of Science ®Google Scholar
• Brunette MF, Mueser KT, Xie H, Drake RE. Relationships between symptoms of schizophrenia and substance abuse. J Nerv Ment Dis 1997; 185: 13–20
   PubMed Web of Science ®Google Scholar
• Goswami S, Mattoo SK, Basu D, Singh G. Substance-abusing schizophrenics: do they self-medicate?. Am J Addict 2004; 13: 139–150
   PubMed Web of Science ®Google Scholar
• Schofield D, Tennant C, Nash L, et al. Reasons for cannabis use in psychosis. Aust N Z J Psychiatry 2006; 40: 570–574
   PubMed Web of Science ®Google Scholar
• Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443–455
   PubMed Web of Science ®Google Scholar
• Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand 1992; 85: 127–130
   PubMed Web of Science ®Google Scholar
• Spencer C, Castle D, Michie PT. Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull 2002; 28: 233–247
   PubMed Web of Science ®Google Scholar
• Marchese G, Casti P, Ruiu S, et al. Haloperidol, but not clozapine, produces dramatic catalepsy in Delta9-THC-treated rats: possible clinical implications. Br J Pharmacol 2003; 140: 520–526
   PubMed Web of Science ®Google Scholar
• Sundram S, Copolov D, Dean B. Clozapine decreases [(3)H] CP 55940 binding to the cannabinoid-(1)-receptor in the rat nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol 2005; 371: 428–433
   PubMed Web of Science ®Google Scholar
• Simons J, Correia CJ, Carey KB. A comparison of motives for marijuana and alcohol use among experienced users. Addict Behav 2000; 25: 153–160
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–276
   PubMed Web of Science ®Google Scholar
• Kot T, Serper M. Increased susceptibility to auditory conditioning in hallucinating schizophrenic patients: a preliminary investigation. J Nerv Ment Dis 2002; 190: 282–288
   PubMed Web of Science ®Google Scholar
• Haddock G, Slade PD, Bentall RP. Auditory hallucinations and the verbal transformation effect: the role of suggestions. Pers Individ Differ 1995; 19: 301–306
   Web of Science ®Google Scholar
• De Preux E, Dubois-Arber F, Zobel F. Current trends in illegal drug use and drug related health problems in Switzerland. Swiss Med Wkly 2004; 134: 313–321
   PubMed Web of Science ®Google Scholar